ARMCX3 and metabolic dysfunction-associated steatohepatitis: Concordant with these data obtained in mice, we also found increased ARMCX3 mRNA expression in liver samples from a cohort of patients with NASH showing overt NAFLD, relative to controls (Figure 1B).